PACIRA BIOSCIENCES, INC. Increase (Decrease) in Deferred Revenue
PACIRA BIOSCIENCES, INC. (PCRX) reported Increase (Decrease) in Deferred Revenue of $125.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-28.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2022-02-28
- PACIRA BIOSCIENCES, INC. increase (decrease) in deferred revenue for the quarter ending 2017-03-31 was -$205.00K.
- PACIRA BIOSCIENCES, INC. increase (decrease) in deferred revenue for the quarter ending 2016-12-31 was -$357.00K.
- PACIRA BIOSCIENCES, INC. increase (decrease) in deferred revenue for the quarter ending 2016-09-30 was -$356.00K.
- PACIRA BIOSCIENCES, INC. increase (decrease) in deferred revenue for the quarter ending 2016-06-30 was -$357.00K.
- PACIRA BIOSCIENCES, INC. increase (decrease) in deferred revenue for fiscal 2021 was $125.00K.
- PACIRA BIOSCIENCES, INC. increase (decrease) in deferred revenue for fiscal 2020 was $0.00.
- PACIRA BIOSCIENCES, INC. increase (decrease) in deferred revenue for fiscal 2019 was $0.00.
- PACIRA BIOSCIENCES, INC. increase (decrease) in deferred revenue for fiscal 2016 was -$1.43M.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2021-12-31 | $125.00K 10-K · filed 2022-02-28 | |||
| 2020-12-31 | $0.00 10-K · filed 2022-02-28 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-02-28 | |||
| 2017-03-31 | -$205.00K 10-Q · filed 2017-05-04 | -$562.00K derived: sum of 2 quarters · filed 2017-05-04 | -$918.00K derived: sum of 3 quarters · filed 2017-05-04 | -$1.27M derived: sum of 4 quarters · filed 2017-05-04 |
| 2016-12-31 | -$357.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | -$713.00K derived: sum of 2 quarters · filed 2017-03-01 | -$1.07M derived: sum of 3 quarters · filed 2017-03-01 | -$1.43M 10-K · filed 2017-03-01 |
| 2016-09-30 | -$356.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | -$713.00K derived: sum of 2 quarters · filed 2016-11-02 | -$1.07M 10-Q · filed 2016-11-02 | -$1.43M derived: sum of 4 quarters · filed 2017-05-04 |
| 2016-06-30 | -$357.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | -$713.00K 10-Q · filed 2016-08-04 | -$1.07M derived: sum of 3 quarters · filed 2017-05-04 | -$1.43M derived: sum of 4 quarters · filed 2017-05-04 |
| 2016-03-31 | -$356.00K 10-Q · filed 2017-05-04 | -$713.00K derived: sum of 2 quarters · filed 2017-05-04 | -$1.07M derived: sum of 3 quarters · filed 2017-05-04 | -$1.43M derived: sum of 4 quarters · filed 2017-05-04 |
| 2015-12-31 | -$357.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | -$713.00K derived: sum of 2 quarters · filed 2017-03-01 | -$1.07M derived: sum of 3 quarters · filed 2017-03-01 | -$1.43M 10-K · filed 2017-03-01 |
| 2015-09-30 | -$356.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | -$713.00K derived: sum of 2 quarters · filed 2016-11-02 | -$1.07M 10-Q · filed 2016-11-02 | $5.64M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | -$357.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | -$713.00K 10-Q · filed 2016-08-04 | $6.00M derived: sum of 3 quarters · filed 2017-03-01 | $5.64M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | -$356.00K 10-Q · filed 2016-05-02 | $6.36M derived: sum of 2 quarters · filed 2017-03-01 | $6.00M derived: sum of 3 quarters · filed 2017-03-01 | $13.68M derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $6.71M 10-K · filed 2017-03-01 | $6.36M derived: sum of 2 quarters · filed 2017-03-01 | $14.04M derived: sum of 3 quarters · filed 2017-03-01 | $6.71M 10-K · filed 2016-02-25 |
| 2014-09-30 | -$356.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-27 | $7.32M derived: sum of 2 quarters · filed 2015-10-27 | $7.07M 10-Q · filed 2015-10-27 | $7.33M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-06-30 | $7.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | $7.43M 10-Q · filed 2015-07-30 | $7.68M derived: sum of 3 quarters · filed 2016-02-25 | $7.44M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-03-31 | -$252.00K 10-Q · filed 2015-04-30 | $5.00K derived: sum of 2 quarters · filed 2016-02-25 | -$238.00K derived: sum of 3 quarters · filed 2016-02-25 | -$481.00K derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-12-31 | $257.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $14.00K derived: sum of 2 quarters · filed 2016-02-25 | -$229.00K derived: sum of 3 quarters · filed 2016-02-25 | -$472.00K 10-K · filed 2016-02-25 |
| 2013-09-30 | -$243.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | -$486.00K derived: sum of 2 quarters · filed 2014-10-30 | -$729.00K 10-Q · filed 2014-10-30 | -$1.55M derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-06-30 | -$243.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | -$486.00K 10-Q · filed 2014-07-31 | -$1.30M derived: sum of 3 quarters · filed 2015-02-24 | -$4.78M derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-03-31 | -$243.00K 10-Q · filed 2014-05-01 | -$1.06M derived: sum of 2 quarters · filed 2015-02-24 | -$4.54M derived: sum of 3 quarters · filed 2015-02-24 | -$10.86M derived: sum of 4 quarters · filed 2015-02-24 |
| 2012-12-31 | -$817.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | -$4.29M derived: sum of 2 quarters · filed 2015-02-24 | -$10.61M derived: sum of 3 quarters · filed 2015-02-24 | -$16.78M 10-K · filed 2015-02-24 |
| 2012-09-30 | -$3.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-31 | -$9.79M derived: sum of 2 quarters · filed 2013-10-31 | -$15.96M 10-Q · filed 2013-10-31 | -$14.69M derived: sum of 4 quarters · filed 2014-02-25 |
| 2012-06-30 | -$6.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | -$12.48M 10-Q · filed 2013-08-06 | -$11.21M derived: sum of 3 quarters · filed 2014-02-25 | -$11.88M derived: sum of 4 quarters · filed 2014-02-25 |
| 2012-03-31 | -$6.17M 10-Q · filed 2013-05-08 | -$4.90M derived: sum of 2 quarters · filed 2014-02-25 | -$5.57M derived: sum of 3 quarters · filed 2014-02-25 | -$6.10M derived: sum of 4 quarters · filed 2014-02-25 |
| 2011-12-31 | $1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $598.00K derived: sum of 2 quarters · filed 2014-02-25 | $65.00K derived: sum of 3 quarters · filed 2014-02-25 | $1.06M 10-K · filed 2014-02-25 |
| 2011-09-30 | -$671.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01 | -$1.20M derived: sum of 2 quarters · filed 2012-11-01 | -$204.00K 10-Q · filed 2012-11-01 | -$744.00K derived: sum of 4 quarters · filed 2013-03-07 |
| 2011-06-30 | -$533.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $467.00K 10-Q · filed 2012-08-09 | -$73.00K derived: sum of 3 quarters · filed 2013-03-07 | -$649.00K derived: sum of 4 quarters · filed 2013-03-07 |
| 2011-03-31 | $1.00M 10-Q · filed 2012-05-09 | $460.00K derived: sum of 2 quarters · filed 2013-03-07 | -$116.00K derived: sum of 3 quarters · filed 2013-03-07 | |
| 2010-12-31 | -$540.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-07 | -$1.12M derived: sum of 2 quarters · filed 2013-03-07 | -$2.33M 10-K · filed 2013-03-07 | |
| 2010-09-30 | -$576.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-31 | -$1.79M 10-Q · filed 2011-10-31 | ||
| 2010-06-30 | -$1.21M 10-Q · filed 2011-08-11 | |||
| 2009-12-31 | $3.79M 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |